Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Stem Cell Research|June 14, 2021
Cardiac fibrosis models using human induced pluripotent stem cell-derived cardiac tissues allow anti-fibrotic drug screening in vitroHiroko Iseoka, Shigeru Miyagawa, Yoshiki Sakai, et al.Biological & Pharmaceutical Bulletin|January 8, 2004
The carboxyl terminal sequence of rat transporter associated with antigen processing (TAP)-like (ABCB9) is heterogeneous due to splicing of its mRNAYoko Yamaguchi, Hiroko Iseoka, Ayako Kobayashi, et al.Stem Cell Research & Therapy|February 20, 2020
Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction modelHiroko Iseoka, Shigeru Miyagawa, Atsuhiro Saito, et al.Acta Biomaterialia|January 29, 2016
Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration Layer-by-Layer technique and their application for pharmaceutical assaysYuto Amano, Akihiro Nishiguchi, Michiya Matsusaki, et al.Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|June 23, 2021
Rapid and sensitive mycoplasma detection system using image-based deep learningHiroko Iseoka, Masao Sasai, Shigeru Miyagawa, et al.Transplantation|April 14, 2012
Myoblast sheet can prevent the impairment of cardiac diastolic function and late remodeling after left ventricular restoration in ischemic cardiomyopathyShunsuke Saito, Shigeru Miyagawa, Taichi Sakaguchi, et al.Stem Cell Reports|April 15, 2022
Engineered three-dimensional cardiac tissues maturing in a rotating wall vessel bioreactor remodel diseased hearts in rats with myocardial infarctionTaro Nakazato, Takuji Kawamura, Toshimasa Uemura, et al.Scientific Reports|February 15, 2019
Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical applicationEmiko Ito, Shigeru Miyagawa, Maki Takeda, et al.Tissue Engineering. Part A|May 13, 2017
Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac TissueHiroko Iseoka, Shigeru Miyagawa, Satsuki Fukushima, et al.Tissue Engineering. Part C, Methods|October 3, 2017
Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem CellsMaki Takeda, Shigeru Miyagawa, Satsuki Fukushima, et al.Pageof 2